<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7199731\results\search\drug\results.xml">
  <result pre="virus IVIg, intravenous gammaglobulin PLP, papain-like protease LPV, Lopinavir RTV," exact="ritonavir" post="RDV, Remdesivir NO, Nitric oxide Mpro, Main protease HLA,"/>
  <result pre="PLP, papain-like protease LPV, Lopinavir RTV, ritonavir RDV, Remdesivir NO," exact="Nitric oxide" post="Mpro, Main protease HLA, human leukocyte antigen 1 Introduction"/>
  <result pre="COVID-19, some clinical trials are in progress [10]. Lopinavir and" exact="Ritonavir" post="were used in preliminary clinical studies [3]. Nevertheless, in"/>
  <result pre="et al. [78]. Keil et al. [79] had reported that" exact="vitamin B2" post="and UV light effectively reduced the titer of MERS-CoV"/>
  <result pre="human plasma products. Atherton et al. [80] had reported that" exact="vitamin C" post="increased the resistance of chick embryo tracheal organ cultures"/>
  <result pre="viral mutations [86]. 6.2 Immunoenhancers A combination of interferon-Î±-2a with" exact="ribavirin" post="was administered to patients with severe MERS-CoV infection and"/>
  <result pre="been shown to restore antibody production in old mice [92]." exact="levamisole" post="can act as either an immunostimulant agent or an"/>
  <result pre="SARS-CoV receptor ACE2 were found by Sui et al. [103]." exact="Chloroquine" post="has many interesting biochemical properties including antiviral effects. In"/>
  <result pre="treatment of HIV infection. Lopinavir (LPV) is usually combined with" exact="ritonavir" post="(RTV) to increase and Polygonum and it is also"/>
  <result pre="hepatitis C [110]. Morgenstern et al. [111] had reported that" exact="ribavirin" post="and interferon-Î² synergistically inhibited the replication of SARS-associated coronavirus"/>
  <result pre="and the lack of in vitro efficacy, the use of" exact="ribavirin" post="should be seriously considered for the treatment of COVID-19,"/>
  <result pre="even in combination with other antiviral drugs. The combination of" exact="lopinavir" post="(LPV) with ritonavir (RTV) is widely used as a"/>
  <result pre="with other antiviral drugs. The combination of lopinavir (LPV) with" exact="ritonavir" post="(RTV) is widely used as a boosted protease inhibitor"/>
  <result pre="efficacy of remdesivir. Yamamoto et al. [116] had found that" exact="nelfinavir" post="could strongly inhibit the replication of SARS-CoV. Arbidol and"/>
  <result pre="the reproduction of SARS virus in the cultured cells [117]." exact="Nitric oxide" post="(NO) is a gas with diverse biological activities and"/>
  <result pre="hepatitis B Restore antibody production (Duchateau, Servais et al., 1985)" exact="Levamisole" post="SARSâ€�CoV Immunostimulant agent or immunosuppressive agent (Joffe, Sukha et"/>
  <result pre="Treatment of manyÂ solid tumors (Sui, Li et al., 2004)" exact="Chloroquine" post="SARSâ€�CoV Prevention of malaria in adults (Savarino, Boelaert et"/>
  <result pre="reduce the infection (Cauwenberghs, Feijge et al., 2006) Antiviral treatments" exact="Ribavirin" post="SARSâ€�CoV Treatment of hepatitis C (Ksiazek, Erdman et al.,"/>
  <result pre="virus disease and Marburg virus (Yamamoto, Yang et al., 2004)" exact="Nelfinavir" post="SARSâ€�CoV Treatment of HIV (Mohanasundaram and Sekhar 2018) Arbidol"/>
  <result pre="SARSâ€�CoV Treatment for influenza infection (Khamitov, Loginova et al., 2008)" exact="Nitric oxide" post="SARSâ€�CoV Treatment of inflammatory airway disease (Robbins and Grisham"/>
  <result pre="such treatment is better than a placebo [125]. Lopinavir and" exact="Ritonavir" post="were identified in earlier studies to target the Main"/>
  <result pre="ill patients with severe acute respiratory syndromeJAMA290200337438012865379 89BaumannC.A.BadamchianM.GoldsteinA.L.Thymosin Î±1 antagonizes" exact="dexamethasone" post="and CD3-induced apoptosis of CD4+ CD8+ thymocytes through the"/>
  <result pre="measles. Depressed helper/inducer subpopulation reversed by in vitro treatment with" exact="levamisole" post="and ascorbic acidJ. Clin. Invest.7219839719806604071 94LuoC.LuoH.ZhengS.GuiC.YueL.YuC.Nucleocapsid protein of SARS"/>
  <result pre="receptor associationProc. Natl. Acad. Sci. Unit. States Am.101200425362541 104SavarinoA.BoelaertJ.R.CassoneA.MajoriG.CaudaR.Effects of" exact="chloroquine" post="on viral infections: an old drug against today's diseasesLancet"/>
  <result pre="Res. Commun.326200590590815607755 112TsangK.ZhongN.S.SARS: pharmacotherapyRespirology82003S25S3015018130 113KimU.J.WonE.-J.KeeS.-J.JungS.-I.JangH.-C.Case report Combination therapy with lopinavir/ritonavir," exact="ribavirin" post="and interferon-Î± for Middle East respiratory syndromeAntivir. Ther.21201645545926492219 114AgostiniM.L.AndresE.L.SimsA.C.GrahamR.L.SheahanT.P.LuX.Coronavirus"/>
  <result pre="ritonavir, and interferon beta against MERS-CoVNat. Commun.11202011431911652 116YamamotoN.YangR.YoshinakaY.AmariS.NakanoT.CinatlJ.HIV protease inhibitor" exact="nelfinavir" post="inhibits replication of SARS-associated coronavirusBiochem. Biophys. Res. Commun.318200471972515144898 117KhamitovR.LoginovaS.ShchukinaV.BorisevichS.MaksimovV.ShusterA.Antiviral"/>
  <result pre="122MohanasundaramN.SekharT.Computational studies of molecular targets regarding the adverse effects of" exact="isoniazid" post="drug for tuberculosisCurr. Pharmacogenom. Pers. Med. (Former. Curr. Pharmacogenom.)162018210218"/>
 </snippets>
</snippetsTree>
